You are here

Press Releases

May 22, 2013
WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) focused on diagnostics policy matters, released the following statement on the introduction by Rep. Peter J. Roskam... Read More
April 10, 2013
WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) that represents companies that develop and manufacture medical diagnostic tests, released the following statement in... Read More
April 2, 2013
WASHINGTON, D.C. – AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) that is focused solely on opportunities and challenges facing companies that develop and manufacture medical diagnostic technologies, today announced... Read More
February 15, 2013
Click below to see a larger version of the infographic: Vital Insights: Diagnostics Transforming Care For more information, please contact: Kaira Whitmore @
January 28, 2013
WASHINGTON, D.C. – AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) that is focused solely on opportunities and challenges facing companies that develop and manufacture medical diagnostic technologies, has elected... Read More
October 4, 2012
WASHINGTON, D.C. – A bill on diagnostics payment reform recently was introduced by Reps. Peter J. Roskam (R-Ill) and Leonard Lance (R-NJ) and cosponsored by Rep. Richard E. Neal (D-Mass).  The new legislation, HR 6446, aims to address flaws in the... Read More
September 28, 2012
BOSTON and WASHINGTON, D.C. – DxInsights, a nonprofit, independent organization devoted to educating stakeholders on the value and power of diagnostics, and AdvaMedDx, a division of the Advanced Medical Technology Association (AdvaMed) representing... Read More
June 21, 2012
AdvaMedDx promotes the value of innovative, safe and effective diagnostic tests and advocates for risk-based regulation of all diagnostics. Currently, the Food and Drug Administration (FDA) has regulatory oversight of all diagnostic tests that are... Read More
April 20, 2012
WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, released the following statement regarding the Triage pilot program from the FDA’s Office of In Vitro Diagnostic Device Evaluation and Safety: “AdvaMedDx has long advocated for a risk-... Read More
February 15, 2012
WASHINGTON, D.C. – Andrew Fish, executive director of AdvaMedDx, released the following statement regarding proposed cuts in the Medicare Clinical Laboratory Fee Schedule: “AdvaMedDx is strongly opposed to further cuts in the Medicare Clinical... Read More

Pages